ÂÜÀòÂÒÂ×

Carrie Neuberger is a medical device industry executive with a proven track record of success in developing strategic clinical and regulatory pathways for emerging new medical devices and novel technologies that address unmet clinical needs. She has worked with Innovative Cardiovascular Solutions (ICS) since early 2014. Her experience includes VP of Regulatory Affairs at Maya Medical (acquired by Covidien, 2012), VP RA/CA/QA at Lazarus Effect (acquired by Medtronic, 2015), VP RA/CA/QA at Nfocus Neuromedical (previously CardioVasc, acquired by Covidien, 2013), and regulatory expert for Becker Consulting (Washington DC). Carrie holds a BS in Chemical Engineering from the University of Virginia, has served on the RAC Certification Board for the Regulatory Affairs Professional Society and as Chairman for the SF Bay Area RAPS Chapter. She has been an industry speaker alongside the Food and Drug Administration leadership and with Notified Bodies on numerous topics concerning both US and European regulatory matters.